{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:11:07Z","timestamp":1772755867693,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022MC173"],"award-info":[{"award-number":["ZR2022MC173"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023MC212"],"award-info":[{"award-number":["ZR2023MC212"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.micpath.2025.107912","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:51:00Z","timestamp":1752623460000},"page":"107912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development of a novel nanobody-fused flagellin adjuvant to enhance immunogenicity in a PCV2 subunit vaccine"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3724-3239","authenticated-orcid":false,"given":"Changjiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengrong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.micpath.2025.107912_bib1","first-page":"44","article-title":"Isolation of circovirus from lesions of pigs with postweaning multisystemic wasting syndrome","volume":"39","author":"Ellis","year":"1998","journal-title":"Can. Vet. J."},{"issue":"9","key":"10.1016\/j.micpath.2025.107912_bib2","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3390\/v14092005","article-title":"Porcine circovirus type 2 vaccines: commercial application and research advances","volume":"14","author":"Guo","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.107912_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.12688\/f1000research.13160.2","article-title":"Longitudinal comparison of the humoral immune response and viral load of Porcine circovirus type 2 in pigs with different vaccination schemes under field conditions","volume":"7","author":"Vargas-Bermudez","year":"2018","journal-title":"F1000Res"},{"issue":"8","key":"10.1016\/j.micpath.2025.107912_bib4","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00705-021-05085-z","article-title":"Porcine circovirus type 2 (PCV2) infection in Hebei Province from 2016 to 2019: a retrospective study","volume":"166","author":"Han","year":"2021","journal-title":"Arch. Virol."},{"issue":"Pt 3","key":"10.1016\/j.micpath.2025.107912_bib5","article-title":"Efficacy comparison in cap VLPs of PCV2 and PCV3 as swine vaccine vehicle","volume":"278","author":"Qiu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.micpath.2025.107912_bib6","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3390\/v16121964","article-title":"A subunit vaccine harboring the fusion capsid proteins of Porcine circovirus types 2, 3, and 4 induces protective immune responses in a mouse model","volume":"16","author":"Wang","year":"2024","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.micpath.2025.107912_bib7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.vaccine.2012.11.062","article-title":"Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-\u03b3 in mice","volume":"31","author":"Wang","year":"2013","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.micpath.2025.107912_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28052248","article-title":"Multiepitope subunit peptide-based nanovaccine against Porcine circovirus type 2 (PCV2) elicited high antibody titers in vaccinated mice","volume":"28","author":"Duong","year":"2023","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.micpath.2025.107912_bib9","doi-asserted-by":"crossref","first-page":"9225","DOI":"10.3390\/ijms24119225","article-title":"Progress towards adjuvant development: focus on antiviral therapy","volume":"24","author":"Brai","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.micpath.2025.107912_bib10","doi-asserted-by":"crossref","first-page":"5677","DOI":"10.4049\/jimmunol.1002156","article-title":"Flagellin as an adjuvant: cellular mechanisms and potential","volume":"185","author":"Mizel","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107912_bib11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12917-022-03412-3","article-title":"Different serotypes of Escherichia coli flagellin exert identical adjuvant effects","volume":"18","author":"Pang","year":"2022","journal-title":"BMC Vet. Res."},{"issue":"1","key":"10.1016\/j.micpath.2025.107912_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12917-020-2253-6","article-title":"Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice","volume":"16","author":"Liu","year":"2020","journal-title":"BMC Vet. Res."},{"issue":"10","key":"10.1016\/j.micpath.2025.107912_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1177\/0022034512457684","article-title":"Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine","volume":"91","author":"Sun","year":"2012","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.micpath.2025.107912_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev-animal-021419-083831","article-title":"Applications of nanobodies","volume":"9","author":"Muyldermans","year":"2021","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/j.micpath.2025.107912_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2020.105607","article-title":"Nanobody production can be simplified by direct secretion from Escherichia coli","volume":"170","author":"Iwaki","year":"2020","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.micpath.2025.107912_bib16","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211010117","article-title":"Nanobody conjugates for targeted cancer therapy and imaging","volume":"20","author":"Kang","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.micpath.2025.107912_bib17","first-page":"10","article-title":"Prokaryotic expression of specific nanobody against porcine circovirus type 2 cap protein","volume":"54","author":"Wang","year":"2020","journal-title":"Chin. J. Veter. Drug"},{"issue":"6","key":"10.1016\/j.micpath.2025.107912_bib18","article-title":"Recombinant flagellin-porcine circovirus type 2 cap fusion protein promotes protective immune responses in mice","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.micpath.2025.107912_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.vaccine.2020.12.013","article-title":"Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d","volume":"39","author":"Kim","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.micpath.2025.107912_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/14760584.2018.1457443","article-title":"Flagellin as a vaccine adjuvant","volume":"17","author":"Cui","year":"2018","journal-title":"Expert Rev. Vaccines"},{"issue":"2","key":"10.1016\/j.micpath.2025.107912_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087822","article-title":"Prevention of intestinal allergy in mice by rflaa:ova is associated with enforced antigen processing and TLR5-dependent IL-10 secretion by mDC","volume":"9","author":"Sch\u00fclke","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.micpath.2025.107912_bib22","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1128\/IAI.67.7.3619-3624.1999","article-title":"Salmonella typhi flagella are potent inducers of proinflammatory cytokine secretion by human monocytes","volume":"67","author":"Wyant","year":"1999","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.micpath.2025.107912_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01652176.2023.2234430","article-title":"Mechanisms of circovirus immunosuppression and pathogenesis with a focus on porcine circovirus 2: a review","volume":"43","author":"Feh\u00e9r","year":"2023","journal-title":"Vet. Q."},{"key":"10.1016\/j.micpath.2025.107912_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198044","article-title":"Porcine circoviruses: current status, knowledge gaps and challenges","volume":"286","author":"Opriessnig","year":"2020","journal-title":"Virus Res."},{"key":"10.1016\/j.micpath.2025.107912_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetmic.2024.110088","article-title":"Orf virus as an adjuvant enhances the immune response to a PCV2 subunit vaccine","volume":"293","author":"Sun","year":"2024","journal-title":"Vet. Microbiol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107912_bib26","first-page":"211","article-title":"Fusion expression and immune effect of PCV2 cap protein tandem multiantigen epitopes with CD154\/GM-CSF","volume":"8","author":"Mao","year":"2021","journal-title":"Vet. Sci."},{"issue":"1","key":"10.1016\/j.micpath.2025.107912_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"11","key":"10.1016\/j.micpath.2025.107912_bib28","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jinorgbio.2009.05.019","article-title":"Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration","volume":"103","author":"Shaw","year":"2009","journal-title":"J. Inorg. Biochem."},{"issue":"2\u20133","key":"10.1016\/j.micpath.2025.107912_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s12026-013-8403-1","article-title":"Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity","volume":"56","author":"Shaw","year":"2013","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.micpath.2025.107912_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s11033-024-10146-y","article-title":"Structural engineering of flagellin as vaccine adjuvant: quest for the minimal domain of flagellin for TLR5 activation","volume":"52","author":"Afzal","year":"2025","journal-title":"Mol. Biol. Rep."},{"issue":"17","key":"10.1016\/j.micpath.2025.107912_bib31","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.vaccine.2015.03.006","article-title":"Salmonella flagellin is a potent carrier-adjuvant for peptide conjugate to induce peptide-specific antibody response in mice","volume":"33","author":"Qian","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.micpath.2025.107912_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1697","article-title":"Nanobody-A versatile tool for cancer diagnosis and therapeutics","volume":"13","author":"Liu","year":"2021","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.micpath.2025.107912_bib33","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00216-019-01633-4","article-title":"Nanobody: outstanding features for diagnostic and therapeutic applications","volume":"411","author":"Salvador","year":"2019","journal-title":"Anal. Bioanal. Chem."},{"issue":"9","key":"10.1016\/j.micpath.2025.107912_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/biom14091116","article-title":"A nanobody of PEDV S1 protein: screening and expression in Escherichia coli","volume":"14","author":"Hao","year":"2024","journal-title":"Biomolecules"},{"issue":"23","key":"10.1016\/j.micpath.2025.107912_bib35","doi-asserted-by":"crossref","first-page":"8747","DOI":"10.1021\/acs.analchem.3c00958","article-title":"Shaping nanobodies and intrabodies against proteoforms","volume":"95","author":"Leonard","year":"2023","journal-title":"Anal. Chem."},{"issue":"9","key":"10.1016\/j.micpath.2025.107912_bib36","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1172\/JCI70266","article-title":"Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection","volume":"123","author":"Tokuhara","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.micpath.2025.107912_bib37","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1002\/anie.201509432","article-title":"Structurally defined \u03b1MHC-II nanobody-drug conjugates: a therapeutic and imaging system for B-Cell lymphoma","volume":"55","author":"Fang","year":"2016","journal-title":"Angew Chem. Int. Ed. Engl."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025006370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025006370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:25:52Z","timestamp":1772753152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025006370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":37,"alternative-id":["S0882401025006370"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107912","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a novel nanobody-fused flagellin adjuvant to enhance immunogenicity in a PCV2 subunit vaccine","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107912"}}